Stockreport

Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy [Yahoo! Finance]

Celularity Inc. - Class A  (CELU) 
PDF Transaction expected to generate up to $35 million in upfront and milestone payments Celularity retains exclusive manufacturing rights, creating continued biomaterial [Read more]